Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Twist Bioscience Corp TWST

Healthcare Biotechnology
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of... see more

Recent & Breaking News (NDAQ:TWST)

Twist Bioscience Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

Newsfile January 3, 2023

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile January 3, 2023

Twist Bioscience to Present at the 41st Annual J.P. Morgan Health Care Conference

Business Wire January 3, 2023

TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

Newsfile January 3, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile January 2, 2023

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST

Newsfile January 1, 2023

TWIST BIOSCIENCE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWST

PR Newswire December 30, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Twist Bioscience Corporation - TWST

Newsfile December 30, 2022

TWIST DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their Options

PR Newswire December 30, 2022

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2023 in Twist Lawsuit - TWST

Newsfile December 30, 2022

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile December 30, 2022

TWST SHAREHOLDER ALERT: Jakubowitz Law Reminds Twist Shareholders of a Lead Plaintiff Deadline of February 10, 2023

PR Newswire December 30, 2022

TWST INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm's Attorneys, Securities Fraud Class Action Pending

Newsfile December 29, 2022

TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit

PR Newswire December 29, 2022

ROSEN, A RANKED AND LEADING FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST

Newsfile December 29, 2022

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the Firm

Newsfile December 29, 2022

TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire December 29, 2022

TWIST BIOSCIENCE CORPORATION (TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors Of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Twist Bioscience Corporation (TWST)

Newsfile December 29, 2022

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Twist Bioscience Corporation - TWST

PR Newswire December 28, 2022

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST

PR Newswire December 28, 2022